Eiko LifeSciences Limited (BOM:540204)

Market Cap	728.63M +1.3%
Revenue (ttm)	587.44M +56.1%
Net Income	48.90M +84.6%
EPS	3.27 +64.4%
Shares Out	14.35M
PE Ratio	15.51
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,594
Open	49.98
Previous Close	49.11
Day's Range	47.00 - 53.00
52-Week Range	43.00 - 64.44
Beta	0.23
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Eiko LifeSciences

Eiko LifeSciences Limited, together with its subsidiary, manufactures and supplies specialty chemicals, fine chemicals, and active pharmaceutical ingredients in India and internationally. It offers speciality chemicals and intermediates, such as lasamide, trichloro salicylic acid, chloroacetyl xylidide, and thiodipropionic acid; agrochemical intermediates; and cosmetic emollients, including isopropyl oleate, isopropyl palmitate, methyl myristate, butyl laurate, isopropyl laurate, isopropyl myristate, butyl oleate, methyl myristate, and methyl l...

• Industry: Industrial Organic Chemicals
• Founded: 1977
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540204

Financial Performance

In fiscal year 2026, Eiko LifeSciences's revenue was 525.71 million, an increase of 39.58% compared to the previous year's 376.64 million. Earnings were 44.96 million, an increase of 113.53%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 23, 2026

Data Sources Report a data error